KELLI LASSITER: Open Payments
NPI 1750166914 · CORBIN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$870 in 56 payments from 10 companies in 2025. Trend: 2023 $35 · 2024 $739 · 2025 $870
Food & beverage: $870
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $189 |
| Otsuka America Pharmaceutical, Inc. | 12 | $170 |
| Vanda Pharmaceuticals Inc. | 7 | $143 |
| Janssen Pharmaceuticals, Inc | 4 | $95 |
| Lundbeck LLC | 5 | $83 |
| Alkermes, Inc. | 4 | $75 |
| Teva Pharmaceuticals USA, Inc. | 2 | $40 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $38 |
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $17 |
Products named: REXULTI, VRAYLAR, SPRAVATO, HETLIOZ, FANAPT, LYBALVI, AUSTEDO XR, CAPLYTA.
Industry payments across KY — which companies pay providers there.
